Patents Examined by Ernst Arnold
  • Alkyl benzoate mixtures
    Patent number: 8329147
    Abstract: The invention relates to alkyl benzoate mixtures, the sum of the C12- and C14-alkyl benzoates being greater than or equal to 85%, in relation to the total sum of the alkyl benzoates. The invention also relates to the use of said alkyl benzoate mixtures in cosmetic and/or pharmaceutical preparations, in particular as oil components.
    Type: Grant
    Filed: September 18, 2007
    Date of Patent: December 11, 2012
    Assignee: Cognis IP Management GmbH
    Inventors: Achim Ansmann, Rolf Kawa, Hans-Dieter Clages, Lars Zander
  • Self-preserved aqueous pharmaceutical compositions
    Patent number: 8323630
    Abstract: The present invention is directed to the provision of multi-dose, self-preserved ophthalmic compositions. The compositions possess sufficient antimicrobial activity to satisfy USP preservative efficacy requirements, as well as similar preservative standards (e.g., EP and JP), without requiring the presence of conventional anti-microbial preservative agents, such as benzalkonium chloride. The compositions are effectively preserved by a balanced ionic buffer system containing zinc ions at a concentration of 0.04 to 0.9 mM, preferably 0.04 to 0.4 mM. One aspect of the balanced buffer system is limitation of the amount of buffering anions present to a concentration of 15 mM or less, preferably 5 mM or less. In a preferred embodiment, the compositions also contain borate or, most preferably, one or more borate/polyol complexes. The use of propylene glycol as the polyol in such complexes is strongly preferred.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: December 4, 2012
    Assignee: Alcon Research, Ltd.
    Inventors: Bhagwati P. Kabra, Masood A. Chowhan, L. Wayne Schneider, Wesley Wehsin Han
  • Lustrous and scratch-resistant nail varnish through addition of silanes
    Patent number: 8323626
    Abstract: A nail varnish additive contains a) at least one silane of the general formula wherein the radicals R1, R2, R3, R4 are identical or different, have 1 to 40 carbon atoms and are non-crosslinking, and optionally b) at least one solvent.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: December 4, 2012
    Assignee: Evonik Degussa GmbH
    Inventors: Heike Bergandt, Frank Weinelt
  • Medium chain peroxycarboxylic acid compositions
    Patent number: 8318188
    Abstract: The present invention relates to compositions including medium chain peroxycarboxylic acid, methods for making these compositions, and methods for reducing the population of a microorganism. The compositions can include advantageously high levels of the medium chain peroxycarboxylic acid, can be readily made, and/or can exhibit reduced odor.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: November 27, 2012
    Assignee: Ecolab USA Inc.
    Inventors: Victor F. Man, Joshua P. Magnuson, Steven E. Lentsch
  • Composition and methods for the protection of hair from treated pool water
    Patent number: 8318797
    Abstract: Compositions for treating hair are disclosed. Methods of making and using compositions for treating hair are also disclosed.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: November 27, 2012
    Inventor: S. Katharine Presty
  • Nitrite formulations and their use as nitric oxide prodrugs
    Patent number: 8303995
    Abstract: Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Methods of reducing triglycerides or reducing C-reactive protein levels are also provided.
    Type: Grant
    Filed: August 16, 2010
    Date of Patent: November 6, 2012
    Assignees: Board of Regents, The University of Texas System, Neogenis Laboratories, Inc.
    Inventors: Nathan Scott Bryan, Janet Zand
  • Polyamide-based powder and its use for obtaining an antibacterial coating
    Patent number: 8303970
    Abstract: The present invention relates to a method of covering a metal article with a film formed from the melting of a thin layer of powder comprising: physically blending 99.8 to 97% by weight of at least one polyamide and 0.2 to 3% by weight of an inorganic biocide species consisting of a soluble ceramic in which silver ions are encapsulated to form a powder blend composition; contacting the metal article with said powder composition blend to form a thin layer of said powder on the article; melting the powder blend composition onto the metal article to form a thin coating film; and cooling the coated article; where the powder blend composition is free of zinc compounds.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: November 6, 2012
    Assignee: Arkema France
    Inventors: Adrien Lapeyre, Christian Gancet
  • Nitrite formulations and their use as nitric oxide prodrugs
    Patent number: 8298589
    Abstract: Compositions comprising a nitrite salt, a nitrate salt, and ascorbic acid are provided in several embodiments. Use of said composition in a method of enhancing cardiovascular performance or treating adverse cardiovascular event in a mammal is also provided.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: October 30, 2012
    Assignee: Board of Regents, The University of Texas System
    Inventor: Nathan Scott Bryan
  • Oily dispersion and cosmetic material incorporating this oily dispersion
    Patent number: 8293257
    Abstract: An oily dispersion of an inorganic microparticle oxide powder that exhibits excellent texture has superior compatibility with other cosmetic material components. The oily dispersion contains only two components of a dispersion medium and a surface-treated inorganic microparticle oxide powder, wherein the dispersion medium is an oil, the surface-treated inorganic microparticle oxide powder is a powder surface-treated with branched fatty acid containing isostearic acid as a primary constituent component or a metal salt containing isostearic acid as a primary constituent component at an amount of 1 to 30% by weight with respect to the powder as a base material, and the surface-treated inorganic microparticle oxide powder has a solid concentration of 25% by weight or more and a viscosity of 2,000 mPa·s or less at 25° C. in the preparation of the oily dispersion.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: October 23, 2012
    Assignee: Tayca Corporation
    Inventors: Kazunori Yagi, Naoki Kanda
  • Hydrogenation of caryophellene
    Patent number: 8293217
    Abstract: A process for the hydrogenation of a mixture of caryophyllenes by contact with hydrogen in the presence of a supported catalyst. The resulting products are useful for the application to skin.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: October 23, 2012
    Assignee: E I du Pont de Nemours and Company
    Inventors: Keith W. Hutchenson, Scott Christopher Jackson, Leo Ernest Manzer, Mark A. Scialdone, Mayis Seapan
  • Local administration of gallium compositions to treat pain
    Patent number: 8293268
    Abstract: Provided are methods of treating pain, including neuropathic pain, in human and veterinary individuals. These methods employ locally administrable pharmaceutical gallium compositions, including pharmaceutical gallium compositions suitable for administration to the skin and mucous membranes. The compositions comprise pharmaceutically acceptable gallium compounds, such as gallium maltolate or gallium nitrate, together with pharmaceutically acceptable carriers suitable for local administration, including those suitable for topical administration. The administration of such compositions provides relief from pain, itching, allodynia, hyperalgesia, and related symptoms.
    Type: Grant
    Filed: March 14, 2012
    Date of Patent: October 23, 2012
    Inventor: Lawrence Richard Bernstein
  • Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide
    Patent number: 8293284
    Abstract: The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: October 23, 2012
    Assignee: INO Therapeutics LLC
    Inventors: James S. Baldassarre, Ralf Rosskamp
  • Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide
    Patent number: 8282966
    Abstract: The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: October 9, 2012
    Assignee: INO Therapeutics LLC
    Inventors: James S. Baldassarre, Ralf Rosskamp
  • Insect attractants and their use in methods of insect control
    Patent number: 8277825
    Abstract: The present invention utilizes a fatty acid as an attractant in a method of attracting whiteflies. By using a fatty acid as a whitefly attractant, it is possible to attract whiteflies to a desired location. The fatty acid can be used in a lure or other propagator to provide a dispersion of fatty acid in the air, the variation in the concentration of the fatty acid in the air being such that a whitefly is attracted to the lure as the source of the fatty acid. The use of a fatty acid as an attractant results in significantly higher levels of attraction, as measured by the number of whiteflies attracted to a sticky trap, as compared to the use of color alone.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: October 2, 2012
    Assignee: Keele University
    Inventor: James Gordon Campbell Hamilton
  • Reinforced absorbable synthetic matrix for hemostatic applications
    Patent number: 8273369
    Abstract: The present invention is directed to a reinforced absorbable hemostat comprising at least one hemostatic agent in a single layer of nonwoven synthetic fabric having a mixture of compressed fiber staples of a polyglycolide/polylactide copolymer and a polydioxanone.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: September 25, 2012
    Assignee: Ethicon, Inc.
    Inventors: Olajompo Moloye-Olabisi, Dhanuraj S. Shetty, Robert W. Van Holten, Degang Zhong
  • Plant remediation
    Patent number: 8273364
    Abstract: A method for treating diseased plants, such as turf and trees, includes mixing a quantity of a plant remediation composition with water and applying the plant remediation composition to the diseased plants. The plant remediation composition may include from about 70 up to about 90 volume percent of a potassium silicate, up to 10 volume percent of a sodium silicate, from about 0.25 to about 3.0 volume percent of a surfactant, from about 0.25 to about 3.0 volume percent of a polyol, and the remaining volume percent water. The plant remediation composition may be used to treat plant molds, bacteria and fungi, such as Anthracnose, Fairy Ring, Brown Patch, Dollar Spot, and Snow Mold, and may also be used to prevent and remediate insect infestations.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: September 25, 2012
    Inventors: Louis Jack Norman, Kelly Green
  • Topical drug delivery using phosphatidylcholine
    Patent number: 8273711
    Abstract: The present invention relates to compositions and methods for transdermal drug delivery comprising formulating a phosphatidylcholine carrier composition containing the drug and applying the composition to the skin.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: September 25, 2012
    Assignee: Transdermal Biotechnology, Inc.
    Inventor: Nicholas V. Perricone
  • Hair cosmetic composition
    Patent number: 8268297
    Abstract: A hair cosmetic composition, containing the following Components (A) to (D): (A) benzyl alcohol, from 0.1 to 2% by mass; (B) dipropylene glycol, from 0.5 to 20% by mass; (C) malic acid or a salt thereof, from 0.2 to 10% by mass, in terms of the malic acid; and (D) lactic acid or a salt thereof, from 0.2 to 10% by mass, in terms of the lactic acid; and optionally containing a surfactant (E) at a concentration of 2% by mass or less and at a Component (E)/Component (A) mass ratio falling within a range of from 0 to 5.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: September 18, 2012
    Assignee: Kao Corporation
    Inventor: Masako Ueno
  • Nutritional supplement for use under physiologically stressful conditions
    Patent number: 8263667
    Abstract: A nutritional supplement for use in physiologically stressful conditions is disclosed. The nutritional supplement may include one or more of vitamin A, vitamin E, vitamin D3, vitamin C, vitamin B1, riboflavin, niacin, folic acid, vitamin B6, biotin, pantothenic acid, vitamin B12, magnesium, zinc, selenium, chromium, copper, iron, alpha lipoic acid, lutein and lycopene.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: September 11, 2012
    Assignee: Vertical Pharmaceuticals, Inc.
    Inventors: Steven A. Squashic, Kevin M Hudy, David C. Purdy
  • Solid pharmaceutical preparation
    Patent number: 8263121
    Abstract: The present invention provides a solid preparation containing an insulin sensitizer and an active ingredient (except insulin sensitizers), which shows in vivo dissolution behavior of an insulin sensitizer, which is similar to the dissolution behavior of an insulin sensitizer from “a solid preparation containing an insulin sensitizer alone as an active ingredient”. The present invention provides a solid preparation containing (1) a layer containing an insulin sensitizer, and (2) a layer containing (a) an active ingredient (except insulin sensitizers), (b) microcrystalline cellulose having a mean particle size of 5-25 ?m, (c) microcrystalline cellulose having a mean particle size of 30-100 ?m and (d) polyvinylpyrrolidone K-90.
    Type: Grant
    Filed: April 13, 2005
    Date of Patent: September 11, 2012
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masahiko Koike, Hiroyoshi Koyama, Naoru Hamaguchi